Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 13 (1), 26

Association of rs780094 Polymorphism of Glucokinase Regulatory Protein With Non-Alcoholic Fatty Liver Disease

Affiliations

Association of rs780094 Polymorphism of Glucokinase Regulatory Protein With Non-Alcoholic Fatty Liver Disease

Saba Mohammadi et al. BMC Res Notes.

Abstract

Objective: GCK rs780094 polymorphism is a single nucleotide polymorphism that has been associated with obesity, type II diabetes and dyslipidemia in some populations, conditions that highly related to NAFL etiology. The present study aimed to evaluate the relationship between NAFLD and rs780094 polymorphism in patients with NAFLD in Tabriz city, northwest of Iran. The rs780094 polymorphism was determined in 74 patients with NAFLD by PCR-RFLP technique. Demographic information was collected using a questionnaire and biochemical analysis was performed using standard laboratory methods.

Results: There was a significant difference between case and control subjects for alanine aminotransferase, aspartate aminotransferase, HDL-C and triglycerides (P < 0.05). Analysis by PCR-RFLP method revealed that there were no significant differences between NAFLD and healthy subjects for rs780094 polymorphism in the study population. The results of this study indicated that rs780094 polymorphism is not associated with NAFLD in subjects from Tabriz city.

Keywords: Biochemical parameters; Demographic parameters; NAFLD; rs780094 polymorphism.

Conflict of interest statement

The authors declare that they have no competing interests.

Similar articles

See all similar articles

References

    1. Ludwig J, Viggiano TR, Mcgill DB, Oh B. Nonalcoholic steatohepatitis Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clinic Proc. 1980;55(7):434–438. - PubMed
    1. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the study of liver diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005–2023. doi: 10.1002/hep.25762. - DOI - PubMed
    1. Andy SY, Keeffe EB. Nonalcoholic fatty liver disease. Gastroenterol Disord. 2002;2(1):B11–B19.
    1. Ioannou GN, Haigh WG, Thorning D, Savard C. Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis. J Lipid Res. 2013;54(5):1326–1334. doi: 10.1194/jlr.M034876. - DOI - PMC - PubMed
    1. Schwimmer JB, Celedon MA, Lavine JE, Salem R, Campbell N, Schork NJ, Shiehmorteza M, Yokoo T, Chavez A, Middleton MS. Heritability of nonalcoholic fatty liver disease. Gastroenterology. 2009;136(5):1585–1592. doi: 10.1053/j.gastro.2009.01.050. - DOI - PMC - PubMed

LinkOut - more resources

Feedback